Results 141 to 150 of about 1,643 (175)
Antioxidant and longevity inducing properties of coconut water on human dermal fibroblasts. [PDF]
Nakorn SN +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
An allopurinol adherence tool using plasma oxypurinol concentrations
British Journal of Clinical Pharmacology, 2022AbstractAimsThis study aimed to develop and evaluate an allopurinol adherence tool based on steady‐state oxypurinol plasma concentrations, allopurinol's active metabolite.MethodsPlasma oxypurinol concentrations were simulated stochastically from an oxypurinol pharmacokinetic model for allopurinol doses of 100‐800 mg daily, accounting for differences in
Natalia Smith‐Diaz +6 more
openaire +2 more sources
Oxypurinol Protects Normothermic Ischemic Hearts
Journal of Cardiac Surgery, 1990Rabbit hearts were mounted on a Langendorff apparatus and after measurement of baseline hemodynamic function exposed to 30 minutes normothermic arrest. Hearts were reperfused at 37 degrees C with buffer solution containing oxypurinol in different concentration: group II (0.01 mM), group III (0.1 mM), group IV (1 mM). Group I did not receive active drug
J, Bergsland +4 more
openaire +2 more sources
Allopurinol and oxypurinol in human breast milk
The Clinical Investigator, 1993To pregnant or breast feeding women drugs should be given with caution. We report the case of a 5-week-old breast-fed infant whose mother was taking 300mg allopurinol/day for 4 weeks. Allopurinol and oxypurinol were detected by HPLC in maternal plasma and breast milk with a method first described here.
I, Kamilli, U, Gresser
openaire +2 more sources
Urinary-Tract Stones Resulting from the Excretion of Oxypurinol
New England Journal of Medicine, 1975COMPOUNDS that inhibit the enzyme, xanthine oxidase, are useful in the treatment of disorders of purine metabolism.
A R, Landgrebe, W L, Nyhan, M, Coleman
openaire +2 more sources
Clinical Pharmacokinetics and Pharmacodynamics of Allopurinol and Oxypurinol
Clinical Pharmacokinetics, 2007Allopurinol is the drug most widely used to lower the blood concentrations of urate and, therefore, to decrease the number of repeated attacks of gout. Allopurinol is rapidly and extensively metabolised to oxypurinol (oxipurinol), and the hypouricaemic efficacy of allopurinol is due very largely to this metabolite.
Richard O, Day +5 more
openaire +2 more sources
Oxypurinol reduces focal ischemic brain injury in the rat
Neuroscience Letters, 1991When measured within 2 days of a unilateral occlusion of the middle cerebral artery (MCA) combined with tandem occlusion of the ipsilateral common carotid artery in rats, contralateral neurological deficits were detectable, with brain swelling and a consistent degree of neocortical infarction in the ipsilateral hemisphere.
Y, Lin, J W, Phillis
openaire +2 more sources
Allergic Reaction to Allopurinol with Cross-Reactivity to Oxypurinol
Annals of Internal Medicine, 1976A 25-year-old white man with gout and nephropathy and with a previous reaction to allopurinol was given a trial dose of oxypurinol. He developed malaise, a generalized erythematous reaction with edema, pruritus, and emesis; this was clinically identical to the reaction he experienced with allopurinol.
O, Lockard +3 more
openaire +2 more sources
Oxypurinol Nephrolithiasis in Regional Enteritis Secondary to Allopurinol Therapy
Annals of Internal Medicine, 1980A patient with regional enteritis and recurrent uric acid nephrolithiasis was treated with allopurinol. While on 600 mg of allopurinol daily, she began to pass many small, soft, yellow stones. Analysis of the stones by liquid chromatographic and gas chromatograph/mass spectrometric techniques revealed that their major constituent was oxypurinol, a ...
R M, Stote +5 more
openaire +2 more sources
Effect of furosemide on renal excretion of oxypurinol and purine bases
Metabolism, 2001To examine whether furosemide affects the plasma concentration and urinary excretion of purine bases and oxypurinol, we administered allopurinol (300 mg) orally to 6 healthy subjects and then administered furosemide (20 mg) intravenously 10 hours later. Furosemide (20 mg) decreased the urinary excretion of uric acid by 40% (P < .01), oxypurinol by 39% (
T, Yamamoto +4 more
openaire +2 more sources

